Taysha (TSHA) Form 144 Notifies Sale of 57,054 RSU-Settled Shares

Rhea-AI Filing Summary

Taysha Gene Therapies, Inc. (TSHA) filing a Form 144 notifies the proposed sale of 57,054 shares of common stock through Maxim Group LLC on 08/21/2025 on Nasdaq. The filing shows these shares were acquired the same day as a vested RSU award from the issuer and settled in stock, with the stated consideration being the reporting person’s continued service as an employee. The filing reports no other sales in the past three months and includes the standard representation that the seller has no undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: A routine insider sale of vested RSUs reported via Form 144; transaction details are limited and appear administrative.

The filing documents a proposed sale of 57,054 common shares via Maxim Group LLC on 08/21/2025, acquired as vested RSUs settled in stock on the same date. The disclosure indicates the transaction arose from compensation rather than a secondary-market transfer. No other sales in the prior three months are reported. From a disclosure perspective, this is a standard compliance filing to notify the market of an insider sale; the filing does not include pricing beyond aggregate market value and provides no broader operational or financial information.

Corporate Governance Expert

TL;DR: Form 144 properly records an employee’s RSU settlement and intended brokered sale; it is a routine governance disclosure.

The filing identifies the broker (Maxim Group LLC) and indicates the securities resulted from an RSU award settled in stock, with consideration described as continued employment. The document contains the typical signature/representation language regarding material nonpublic information. There is no indication in this filing of unusual timing, multiple sellers, or aggregate sales requiring further aggregation disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Maxim Group LLC 300 Park Avenue, 16th Floor New York NY 10022	57054	163744.98	272794885	08/21/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/21/2025	RSU Award	Issuer			57054	08/21/2025	Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TSHA Form 144 filed on 08/21/2025 report?

It reports a proposed sale of 57,054 shares of Taysha Gene Therapies common stock through Maxim Group LLC, acquired as vested RSUs and settled in stock.

Who is the broker named in the TSHA Form 144?

Maxim Group LLC (300 Park Avenue, 16th Floor, New York, NY 10022) is listed as the broker for the proposed sale.

Were these shares newly acquired or purchased earlier?

The shares were acquired on 08/21/2025 as a vested RSU award from the issuer and settled in stock on that date.

Does the filing report other sales by the reporting person in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

What exchange is the proposed sale expected to occur on?

Nasdaq is listed as the securities exchange for the proposed sale.